Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Non-Current Assets (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Non-Current Assets for 11 consecutive years, with $23.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 25.55% year-over-year to $23.7 million, compared with a TTM value of $23.7 million through Dec 2025, down 25.55%, and an annual FY2025 reading of $23.7 million, down 25.55% over the prior year.
  • Non-Current Assets was $23.7 million for Q4 2025 at Wave Life Sciences, down from $25.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $53.2 million in Q2 2022 and bottomed at $23.7 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $40.0 million, with a median of $41.9 million recorded in 2021.
  • The sharpest move saw Non-Current Assets crashed 45.82% in 2021, then rose 17.76% in 2022.
  • Year by year, Non-Current Assets stood at $44.4 million in 2021, then grew by 7.66% to $47.8 million in 2022, then dropped by 17.29% to $39.6 million in 2023, then fell by 19.62% to $31.8 million in 2024, then decreased by 25.55% to $23.7 million in 2025.
  • Business Quant data shows Non-Current Assets for WVE at $23.7 million in Q4 2025, $25.9 million in Q3 2025, and $28.8 million in Q2 2025.